315 related articles for article (PubMed ID: 29079562)
1. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
Younis A; Younis A; Tzur B; Peled Y; Shlomo N; Goldenberg I; Fisman EZ; Tenenbaum A; Klempfner R
Cardiovasc Diabetol; 2016 Oct; 15(1):149. PubMed ID: 27793156
[TBL] [Abstract][Full Text] [Related]
3. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
4. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
[TBL] [Abstract][Full Text] [Related]
5. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis.
Fisman EZ; Motro M; Tenenbaum A; Boyko V; Mandelzweig L; Behar S
Am Heart J; 2001 Mar; 141(3):485-90. PubMed ID: 11231448
[TBL] [Abstract][Full Text] [Related]
6. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
[TBL] [Abstract][Full Text] [Related]
7. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
Bergman M; Chetrit A; Roth J; Dankner R
Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome is not associated with increased mortality or cardiovascular risk in nondiabetic patients with a new diagnosis of coronary artery disease.
Petersen JL; Yow E; AlJaroudi W; Shaw LK; Goyal A; McGuire DK; Peterson ED; Harrington RA
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):165-72. PubMed ID: 20179266
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome predicts long-term mortality in subjects without established diabetes mellitus in asymptomatic Korean population: A propensity score matching analysis from the Korea Initiatives on Coronary Artery Calcification (KOICA) registry.
Won KB; Chang HJ; Han D; Sung J; Choi SY
Medicine (Baltimore); 2016 Dec; 95(49):e5421. PubMed ID: 27930521
[TBL] [Abstract][Full Text] [Related]
11. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
[TBL] [Abstract][Full Text] [Related]
12. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Ritsinger V; Brismar K; Malmberg K; Mellbin L; Näsman P; Rydén L; Söderberg S; Tenerz Å; Norhammar A
Diab Vasc Dis Res; 2017 Mar; 14(2):77-87. PubMed ID: 28185529
[TBL] [Abstract][Full Text] [Related]
14. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
[TBL] [Abstract][Full Text] [Related]
16. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study.
Chen S; Li J; Li Q; Qiu Z; Wu X; Chen L
BMC Cardiovasc Disord; 2019 Jan; 19(1):25. PubMed ID: 30674287
[TBL] [Abstract][Full Text] [Related]
18. Impaired fasting glucose association with mortality in nondiabetic patients on maintenance peritoneal dialysis.
Chen KH; Lin JL; Hung CC; Lin-Tan DT; Weng SM; Yen TH; Hsu CW; Yang CW
Am J Med Sci; 2011 Apr; 341(4):312-7. PubMed ID: 21289510
[TBL] [Abstract][Full Text] [Related]
19. Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up.
Fisman EZ; Motro M; Tenenbaum A; Leor J; Boyko V; Mandelzweig L; Sherer Y; Adler Y; Behar S
Eur J Cardiovasc Prev Rehabil; 2004 Apr; 11(2):135-43. PubMed ID: 15187817
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus.
Blanke P; Naoum C; Ahmadi A; Cheruvu C; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Chow BW; Min J; Leipsic J
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1280-1288. PubMed ID: 27568114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
